Constructing a Conceptual Framework of Patient-Reported Outcomes for Metastatic Hormone-Refractory Prostate Cancer

被引:29
作者
Eton, David T. [1 ]
Shevrin, Daniel H. [2 ]
Beaumont, Jennifer [3 ]
Victorson, David [3 ]
Cella, David [3 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN 55905 USA
[2] NorthShore Univ HealthSyst, Kellogg Canc Care Ctr, Evanston, IL USA
[3] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
conceptual framework; hormone-refractory; patient-reported outcomes; prostate cancer; quality of life; QUALITY-OF-LIFE; MITOXANTRONE PLUS PREDNISONE; RANDOMIZED-TRIAL; MODEL; DOCETAXEL; MEN; ESTRAMUSTINE;
D O I
10.1111/j.1524-4733.2010.00702.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: A conceptual framework for patient-reported outcomes (PROs) is a structured representation of outcome concepts and issues. Our aim was to develop a conceptual framework of PROs for hormone-refractory prostate cancer (HRPC) to support measurement clarity. Methods: Relevant outcome issues were identified from review of recent clinical trials. This provided content for an interview with 15 metastatic HRPC patients and a survey of 10 practitioners. All participants were asked about the relevance and importance of 26 outcomes and were allowed to nominate new outcomes. Practitioners were also asked to determine which outcomes endorsed by patients were attributable to the disease (symptoms) versus treatment (side effects). Analyses of archived clinical trial data were used to verify and augment the interview and survey results. Results: Patients endorsed 11 concerns as relevant and important to HRPC including general pain, bone pain, urinary problems, fatigue, appetite loss, constipation, erectile dysfunction, peripheral neuropathy, diarrhea, PSA anxiety, and changes in self image. Practitioner judgments helped classify each concern into one of four categories, disease symptom, treatment side effect, both symptom and side effect, or psychological concern. Additionally, patients endorsed (and practitioners confirmed) the relevance and importance of several general domains of quality of life. Analyses of archived data confirmed the importance of these issues and suggested two additional concerns. Conclusion: Findings were used to propose a conceptual framework of PROs for metastatic HRPC. Such frameworks can be used to help specify targets for assessment in clinical studies such as treatment trials.
引用
收藏
页码:613 / 623
页数:11
相关论文
共 26 条
  • [1] [Anonymous], 2008, Cancer facts and figures
  • [2] Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy
    Basch, Ethan
    Iasonos, Alexia
    Barz, Allison
    Culkin, Ann
    Kris, Mark G.
    Artz, David
    Fearn, Paul
    Speakman, John
    Farquhar, Rena
    Scher, Howard I.
    McCabe, Mary
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5374 - 5380
  • [3] Quality of life and pain in advanced stage prostate cancer: Results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
    Berry, Donna L.
    Moinpour, Carol M.
    Jiang, Caroline S.
    Ankerst, Donna Pauler
    Petrylak, Daniel P.
    Vinson, Lynne V.
    Lara, Primo N.
    Jones, Sharon
    Taplin, Mary E.
    Burch, Patrick A.
    Hussain, Maha H. A.
    Crawford, E. David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2828 - 2835
  • [4] Role of quality of life in men with metastatic hormone-refractory prostate cancer: How does atrasentan influence quality of life?
    Cella, D
    Petrylak, DP
    Fishman, M
    Teigland, C
    Young, J
    Mulani, P
    [J]. EUROPEAN UROLOGY, 2006, 49 (05) : 781 - 789
  • [5] [Center for Drug Evaluation and Research U.S. Department of Health and Human Services], 2006, GUID IND PAT REP OUT
  • [6] Epothilones in prostate cancer: review of clinical experience
    Dawson, N. A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : V22 - V27
  • [7] DONATTI C, 2008, ISPOR CONNECTIONS, P9
  • [8] Conceptual model of health-related quality of life
    Ferrans, CE
    Zerwic, JJ
    Wilbur, JE
    Larson, JL
    [J]. JOURNAL OF NURSING SCHOLARSHIP, 2005, 37 (04) : 336 - 342
  • [9] How many interviews are enough? An experiment with data saturation and variability
    Guest, Greg
    Bunce, Arwen
    Johnson, Laura
    [J]. FIELD METHODS, 2006, 18 (01) : 59 - 82
  • [10] Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions
    Lepore, SJ
    Helgeson, VS
    Eton, DT
    Schulz, R
    [J]. HEALTH PSYCHOLOGY, 2003, 22 (05) : 443 - 452